Literature DB >> 29286360

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment.

Marta H Kubala1, Yves A DeClerck2.   

Abstract

siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system1, and the tetracycline regulated gene expression systems. The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29286360      PMCID: PMC5755478          DOI: 10.3791/56333

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  36 in total

1.  Characteristics of adenovirus-mediated tetracycline-controllable expression system.

Authors:  H Mizuguchi; T Hayakawa
Journal:  Biochim Biophys Acta       Date:  2001-11-07

2.  Negative selection of human monocytes using magnetic particles covered by anti-lymphocyte antibodies.

Authors:  R W Flø; A Naess; F Lund-Johansen; B O Maehle; H Sjursen; V Lehmann; C O Solberg
Journal:  J Immunol Methods       Date:  1991-03-01       Impact factor: 2.303

3.  Assay of chemotaxis by a reversible Boyden chamber eliminating cell detachment.

Authors:  T W Jungi
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

4.  Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1).

Authors:  C Borgfeldt; S R Hansson; B Gustavsson; A Måsbäck; B Casslén
Journal:  Int J Cancer       Date:  2001-05-15       Impact factor: 7.396

Review 5.  Macrophages and therapeutic resistance in cancer.

Authors:  Brian Ruffell; Lisa M Coussens
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

6.  Effect of Sorbus commixta on the invasion and migration of human hepatocellular carcinoma Hep3B cells.

Authors:  Hyerin Park; Hyunwook Park; Tae-Wook Chung; Hee-Jung Choi; Yeon-Seop Jung; Syng-Ook Lee; Ki-Tae Ha
Journal:  Int J Mol Med       Date:  2017-06-02       Impact factor: 4.101

Review 7.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

8.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

9.  Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.

Authors:  Yan Ji; Zhen Weng; Philip Fish; Neha Goyal; Mao Luo; Samantha P Myears; Tammy L Strawn; Bysani Chandrasekar; Jianbo Wu; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-22       Impact factor: 8.311

10.  MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.

Authors:  Valeria Solari; Lucia Borriello; Gianluca Turcatel; Hiroyuki Shimada; Richard Sposto; G Esteban Fernandez; Shahab Asgharzadeh; Edwin A Yates; Jeremy E Turnbull; Yves A DeClerck
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

View more
  1 in total

1.  Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.

Authors:  Marta Helena Kubala; Vasu Punj; Veronica Rae Placencio-Hickok; Hua Fang; G Esteban Fernandez; Richard Sposto; Yves Albert DeClerck
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.